Implementing Brain Health PRO Across Diverse Settings: A Multi-Site Implementation Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Brain Health PRO (BHPRO): A 6-month, web-based dementia-risk-reduction program consisting of eight modules addressing modifiable risk factors: physical activity, diet, cognitive engagement, sleep, social and psychological health, vascular health, and vision/hearing health. Upon registration, participants complete baseline lifestyle questionnaires that generate a personalized risk profile. Participants are instructed to prioritize three risk domains based on their profile and receive tailored content accordingly. Materials include narrated educational content, visual aids, quizzes, interactive exercises, and evidence-based recommendations. Content is delivered gradually (four 10-minute chapters per week). All modules remain accessible throughout participation. Program engagement metrics, including chapter completion, are automatically captured through the platform.
Study summary
Brain Health PRO (BHPRO) is a 6-month, web-based dementia-risk-reduction program targeting modifiable risk factors for cognitive decline. This 12-months, multi-site, single-arm, mixed-methods implementation study (Hybrid Type III design) evaluates the real-world adoption, sustainability, and reach of BHPRO across 10-14 partner sites in Canada, spanning seven provinces, including community organizations, clinics, and a public-health agency, with emphasis on rural and underserved communities. Tailored implementation toolkits (BHPRO-ITs), co-developed during Phase 1 using the ERIC taxonomy, are deployed at each site. Implementation outcomes (adoption, sustainability, reach, appropriateness, feasibility) are assessed at provider and organizational levels via online questionnaires and twice-monthly champion meetings. Effectiveness outcomes (dementia literacy, self-efficacy, modifiable risk factor composite, cognition) are collected from end users (adults aged 50+, at risk of dementia) at baseline, 3 months, post-program (6 months), and follow-up (12 months).
Eligibility
Primary outcome measure(s)
- Implementation outcome = Adoption — 3 months after rollout initiation at each site
The delivery of the intervention by the sites. Measure: Site implementation logs and twice-monthly champion reports; quantitative questionnaires Benchmark: ≥70% of sites adopt within 3 months of rollout. - Implementation outcome = Sustainability — 12 months after rollout initiation at each site
The extent to which the intervention continues to be delivered by the sites one year after starting implementation. Measure: Site implementation logs; program delivery logs; site documentation; focus groups. Benchmark: ≥64% of adopting sites. - Implementation outcome = Reach — 6 months and 12 months after rollout
Participants from the sites who start the program. Benchmark: ≥67%. BHPRO platform analytics (automated backend); Reach Reporter (site champions, every 6 months). - Implementation outcome = Barriers and Facilitators to Implementation (Qualitative) — 3, 6, and 12 months post-rollout
Multi-level barriers and facilitators to BHPRO adoption and sustainability. Measurements: Semi-structured focus groups with site staff (60-90 min, audio-recorded, transcribed verbatim); monthly online meetings with site champions; analyzed using reflexive thematic analysis (inductive + deductive CFIR/RE-AIM framework). NVivo. \~20% double-coded.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal | Montreal | Quebec | Recruiting |
More Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07935629 on ClinicalTrials.gov ↗ ← All trials in Canada